Lidocaine antibody
Quick Overview for Lidocaine antibody (ABIN1001358)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Lidocaine
-
Specificity
- ELISA microtitre plate based and expressed as % crossreactivity*. The antibody exhibited crossreactivity for the following compounds: Norlidocaine < 2.3 %
-
Purification
- Salt fractionation.
-
Immunogen
- Lidocaine-BTG
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Application_Dilutions: 1.25 μg/mL
Tested_Applications: The antibody is suitable for the development of immunoassays or immunoaffinity purification columns.
-
Comment
-
10 ng/mL Lidocaine produces 84 % inhibition in a competitive ELISA employing Lidocaine polyclonal antibody.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride. pH 7.4, 0.09 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Can be stored for up to 3 months at +2°C - +8°C. For long term storage, aliquot and store at ≤-20 °C. Avoid repeated freeze/thaw cycles. Product should be protected from light exposure.
-
-
- Lidocaine
-
Target Type
- Chemical
-
Background
- A local anaesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.
Target
-